BRCA2 MUTATION

Clinical trials for BRCA2 MUTATION explained in plain language.

Never miss a new study

Get alerted when new BRCA2 MUTATION trials appear

Sign up with your email to follow new studies for BRCA2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 13 Not yet recruiting 1 Not yet finished but already full! 6 Completed 2 Terminated 1

New test may expand who benefits from ovarian cancer drug

Knowledge-focused Terminated

This study tested a new lab method (RAD51 assay) to see if it could better predict which patients with recurrent ovarian cancer would respond to the drug olaparib. The goal was to find more patients who could benefit, beyond those with BRCA gene mutations. The study was stopped e…

Matched conditions: BRCA2 MUTATION

Phase: PHASE2 • Sponsor: Leiden University Medical Center • Aim: Knowledge-focused

Last updated Jun 16, 2026 20:49 UTC

BRCA2 MUTATION

Get alerted when new BRCA2 MUTATION trials appear

New test may expand who benefits from ovarian cancer drug